Andreas Evdokiou

5.2k total citations
100 papers, 4.2k citations indexed

About

Andreas Evdokiou is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Andreas Evdokiou has authored 100 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 43 papers in Oncology and 19 papers in Immunology. Recurrent topics in Andreas Evdokiou's work include Bone health and treatments (21 papers), Bone Metabolism and Diseases (18 papers) and Cell death mechanisms and regulation (13 papers). Andreas Evdokiou is often cited by papers focused on Bone health and treatments (21 papers), Bone Metabolism and Diseases (18 papers) and Cell death mechanisms and regulation (13 papers). Andreas Evdokiou collaborates with scholars based in Australia, United States and Japan. Andreas Evdokiou's co-authors include David M. Findlay, Gerald J. Atkins, Shelley Hay, Stelios Bouralexis, Andrew C.W. Zannettino, Dušan Lošić, Agatha Labrinidis, Abel Santos, Asiri R. Wijenayaka and Vasilios Liapis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Cancer.

In The Last Decade

Andreas Evdokiou

100 papers receiving 4.1k citations

Peers

Andreas Evdokiou
Jianru Xiao China
Chao Xie China
Vladislav Volarević Serbia
Guanbin Song China
Hideo Morioka Japan
Jeong‐Hwa Baek South Korea
Minoru Takagi Japan
Shih‐Chieh Hung Taiwan
John M. Whitelock Australia
Akihiko Matsumine Japan
Jianru Xiao China
Andreas Evdokiou
Citations per year, relative to Andreas Evdokiou Andreas Evdokiou (= 1×) peers Jianru Xiao

Countries citing papers authored by Andreas Evdokiou

Since Specialization
Citations

This map shows the geographic impact of Andreas Evdokiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Evdokiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Evdokiou more than expected).

Fields of papers citing papers by Andreas Evdokiou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Evdokiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Evdokiou. The network helps show where Andreas Evdokiou may publish in the future.

Co-authorship network of co-authors of Andreas Evdokiou

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Evdokiou. A scholar is included among the top collaborators of Andreas Evdokiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Evdokiou. Andreas Evdokiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamaguchi, Haruka, Namfon Pantarat, Takamasa Suzuki, & Andreas Evdokiou. (2019). Near-Infrared Photoimmunotherapy Using a Small Protein Mimetic for HER2-Overexpressing Breast Cancer. International Journal of Molecular Sciences. 20(23). 5835–5835. 23 indexed citations
2.
Maher, Shaheer, et al.. (2017). Engineering of Micro- to Nanostructured 3D-Printed Drug-Releasing Titanium Implants for Enhanced Osseointegration and Localized Delivery of Anticancer Drugs. ACS Applied Materials & Interfaces. 9(35). 29562–29570. 69 indexed citations
3.
Maher, Shaheer, Abel Santos, Tushar Kumeria, et al.. (2017). Multifunctional microspherical magnetic and pH responsive carriers for combination anticancer therapy engineered by droplet-based microfluidics. Journal of Materials Chemistry B. 5(22). 4097–4109. 32 indexed citations
4.
Gulati, Karan, Irene Zinonos, Ye Wang, et al.. (2016). Titanium wire implants with nanotube arrays: A study model for localized cancer treatment. Biomaterials. 101. 176–188. 39 indexed citations
5.
Panagopoulos, Vasilios, Irene Zinonos, Damien A. Leach, et al.. (2015). Uncovering a new role for peroxidase enzymes as drivers of angiogenesis. The International Journal of Biochemistry & Cell Biology. 68. 128–138. 28 indexed citations
6.
Zinonos, Irene, Ke-Wang Luo, Agatha Labrinidis, et al.. (2014). Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. International Journal of Oncology. 45(2). 532–540. 19 indexed citations
7.
Liapis, Vasilios, Agatha Labrinidis, Irene Zinonos, et al.. (2014). Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma. Cancer Letters. 357(1). 160–169. 41 indexed citations
8.
Pishas, Kathleen I., Susan J. Neuhaus, Mark Clayer, et al.. (2013). Nutlin-3a Efficacy in Sarcoma Predicted by Transcriptomic and Epigenetic Profiling. Cancer Research. 74(3). 921–931. 22 indexed citations
9.
Hodson, Leigh J., et al.. (2013). Macrophage Phenotype in the Mammary Gland Fluctuates over the Course of the Estrous Cycle and Is Regulated by Ovarian Steroid Hormones1. Biology of Reproduction. 89(3). 65–65. 29 indexed citations
10.
Liapis, Vasilios, Andreas Evdokiou, Constantina Constantinou, et al.. (2012). Induction of discrete apoptotic pathways by bromo-substituted indirubin derivatives in invasive breast cancer cells. Biochemical and Biophysical Research Communications. 425(1). 76–82. 27 indexed citations
11.
Endo‐Munoz, Liliana, A. Cumming, Danny Rickwood, et al.. (2010). Loss of Osteoclasts Contributes to Development of Osteosarcoma Pulmonary Metastases. Cancer Research. 70(18). 7063–7072. 63 indexed citations
12.
Pishas, Kathleen I., Fares Al‐Ejeh, Irene Zinonos, et al.. (2010). Nutlin-3a Is a Potential Therapeutic for Ewing Sarcoma. Clinical Cancer Research. 17(3). 494–504. 59 indexed citations
13.
Zinonos, Irene, Agatha Labrinidis, Michelle Lee, et al.. (2009). Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer. Molecular Cancer Therapeutics. 8(10). 2969–2980. 37 indexed citations
14.
Dwivedi, Prem P., Andreas Evdokiou, Antonio Ferrante, et al.. (2009). A role for the phosphatidylinositol 3-kinase – protein kinase C zeta – Sp1 pathway in the 1,25-dihydroxyvitamin D3 induction of the 25-hydroxyvitamin D3 24-hydroxylase gene in human kidney cells. Cellular Signalling. 22(3). 543–552. 31 indexed citations
15.
Bouralexis, Stelios, David M. Findlay, & Andreas Evdokiou. (2005). Death to the bad guys: Targeting cancer via Apo2L/TRAIL. APOPTOSIS. 10(1). 35–51. 107 indexed citations
16.
Bouralexis, Stelios, et al.. (2002). Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanism. Journal of Endocrinology. 175(3). 715–725. 13 indexed citations
17.
Atkins, Gerald J., David R. Haynes, Stephen E. Graves, et al.. (2000). Expression of Osteoclast Differentiation Signals by Stromal Elements of Giant Cell Tumors. Journal of Bone and Mineral Research. 15(4). 640–649. 158 indexed citations
18.
19.
Evdokiou, Andreas, et al.. (2000). Identification of a novel calcitonin-response element in the promoter of the human p21WAF1/CIP1 gene. Journal of Molecular Endocrinology. 25(2). 195–206. 11 indexed citations
20.
Evdokiou, Andreas & Prue Cowled. (1998). Growth-Regulatory Activity of the Growth Arrest-Specific Gene, GAS1, in NIH3T3 Fibroblasts. Experimental Cell Research. 240(2). 359–367. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianru Xiao Breakdown of academic impact, for papers by Chao Xie Breakdown of academic impact, for papers by Vladislav Volarević Breakdown of academic impact, for papers by Guanbin Song Breakdown of academic impact, for papers by Hideo Morioka Breakdown of academic impact, for papers by Jeong‐Hwa Baek Breakdown of academic impact, for papers by Minoru Takagi Breakdown of academic impact, for papers by Shih‐Chieh Hung Breakdown of academic impact, for papers by John M. Whitelock Breakdown of academic impact, for papers by Akihiko Matsumine
Rankless by CCL
2026